The revenue of Leap Therapeutics with headquarters in the United States amounted to *** million U.S. dollars in 2021. The reported fiscal year ends on December 31.
The earliest shown value from 2020 exhibits a nearly identical value to 2021. The trend from 2020 to 2021 shows, furthermore, very little fluctuations in between.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
U.S. Securities and Exchange Commission. (October 24, 2024). Revenue of Leap Therapeutics from 2020 to 2021 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/1503825/leap-therapeutics-revenue/
U.S. Securities and Exchange Commission. "Revenue of Leap Therapeutics from 2020 to 2021 (in million U.S. dollars)." Chart. October 24, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/1503825/leap-therapeutics-revenue/
U.S. Securities and Exchange Commission. (2024). Revenue of Leap Therapeutics from 2020 to 2021 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/1503825/leap-therapeutics-revenue/
U.S. Securities and Exchange Commission. "Revenue of Leap Therapeutics from 2020 to 2021 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 Oct 2024, /statistics/1503825/leap-therapeutics-revenue/
U.S. Securities and Exchange Commission, Revenue of Leap Therapeutics from 2020 to 2021 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1503825/leap-therapeutics-revenue/ (last visited July 22, 2026)
Revenue of Leap Therapeutics from 2020 to 2021 (in million U.S. dollars) [Graph], U.S. Securities and Exchange Commission, October 24, 2024. [Online]. Available: /statistics/1503825/leap-therapeutics-revenue/
